Page last updated: 2024-09-05

etravirine and l 737126

etravirine has been researched along with l 737126 in 2 studies

Compound Research Comparison

Studies
(etravirine)
Trials
(etravirine)
Recent Studies (post-2010)
(etravirine)
Studies
(l 737126)
Trials
(l 737126)
Recent Studies (post-2010) (l 737126)
572903211002

Protein Interaction Comparison

ProteinTaxonomyetravirine (IC50)l 737126 (IC50)
Gag-Pol polyproteinHIV-1 M:B_HXB2R0.075
Reverse transcriptase/RNaseH Human immunodeficiency virus 10.0707
Protease Human immunodeficiency virus 10.0875

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
De Clercq, E; Li, D; Liu, X; Zhan, P1
Armijos Rivera, JI; Badia, R; Brambilla, A; Catalano, M; Cinquina, E; Coluccia, A; Crespan, E; Esté, JA; Falasca, F; La Regina, G; Limatola, C; Maga, G; Masci, D; Nalli, M; Riveira-Muñoz, E; Silvestri, R; Turriziani, O1

Other Studies

2 other study(ies) available for etravirine and l 737126

ArticleYear
Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms.
    Journal of medicinal chemistry, 2012, Apr-26, Volume: 55, Issue:8

    Topics: Anti-HIV Agents; Benzodiazepines; Binding Sites; Crystallography, X-Ray; Drug Design; HIV Reverse Transcriptase; HIV-1; Hydrogen Bonding; Imidazoles; Indoles; Nitriles; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2012
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains.
    European journal of medicinal chemistry, 2020, Dec-15, Volume: 208

    Topics: Anti-HIV Agents; Cell Line, Tumor; Drug Design; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Mutation; Protein Binding; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfones; Zidovudine

2020